Skip to content

Effectiveness of Complete Myocardial Revascularization with saphenous vein Y-graft for Patients with Multivessel coronary heart disease: A Prospective and Observational Study

The study of the clinical application of saphenous vein Y-graft for Patients with Multivessel coronary heart disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014505
Enrollment
Unknown
Registered
2018-01-17
Start date
2018-01-17
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CABG for Patients with Multivessel coronary heart disease

Interventions

patients who underwent simultaneous saphenous vein Y grafts and arterial/venous graft:None
patients who underwent arterial and venous grafts at the same period:None

Sponsors

Key Laboratory of Arrhythmias of the Ministry of Education of China, East Hospital, Tongji University School of Medicine;Department of Cardiovascular Surgery, East Hospital, Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The data of patients with coronary artery bypass grafting were reviewed with reference to the study of Chinese heart surgery registration and the characteristics of patients with coronary artery bypass grafting.

Exclusion criteria

Exclusion criteria: 1. Patients with missing clinical data; 2. age >80 years, left ventricular ejection fraction; 3. <40%,dysfunction of liver or kidney, coagulopathy, use of anticoagulants, positive Allens test result, Raynauds syndrome or vasculitis, previous vein stripping or bilateral varicose veins; 4. Unwilling to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Survival situation;

Secondary

MeasureTime frame
The recurrence rate;

Countries

China

Contacts

Public ContactYangyang Zhang

Shanghai East Hospital of Tongji University School; Tongji University School of Medicine

zhangyangyang_wy@vip.sina.com+86 13818132320

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026